The aim of the present study was to compare the effects of oral glutamine with whole protein low in glutamine on: (i) first- and second- phase insulin response using the gold standard hyperglycemic glucose clamp; and (ii) total and active GLP-1 in well-controlled type 2 diabetes patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.